11 May 2015

Dihydrocodeine Tablets (Dihydrocodeine Tartrate) - United Kingdom

Dihydrocodeine Tablets BP

Generic Matches for Dihydrocodeine Tartrate (2)
DHC Continus prolonged release tablets 60mg, 90mg and 120 mg
Dihydrocodeine Tablets BP 30mg

Last Updated on 11 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Dihydrocodeine Tablets BP Indication

As an analgesic for the relief of moderate to severe pain. Dihydrocodeine Tablets 30mg are indicated in all painful conditions where an alert patient is desired, eg sciatica, osteo-arthritis, chronic rheumatoid arthritis, arthritis of the spine, peripheral vascular disease, post-herpetic neuralgia, Paget's disease, malignant disease, post-operative pain.

Because dihydrocodeine, in the recommended doses, causes little or no respiratory depression, its use in the treatment of post-operative pain may reduce the risk of chest complications.


Dihydrocodeine Tablets BP Generic Name

Dihydrocodeine Tartrate



Summary Product Characteristics (SPCs) Links
SPC - Dihydrocodeine Tablets BP 30mg (external site)

Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this free resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately. Content is arranged into sections with disease awareness information, mode of action videos, first-line treatment options, links to useful external hyperammonaemia content and more… 

Dihydrocodeine Tablets Marketing Information

Dihydrocodeine Tablets Generic Name
Dihydrocodeine Tartrate
Marketing Company
Actavis UK Limited
Drug Type
Date of Issue, Marketing Authority 01/10/1986

Related Drugs - Pain Management

Back to top